A molecular investigation of true dominance in Huntington's disease
- PMID: 10528852
- PMCID: PMC1734229
- DOI: 10.1136/jmg.36.10.739
A molecular investigation of true dominance in Huntington's disease
Abstract
Huntington's disease (HD) is thought to show true dominance, since subjects with two mutant alleles have been reported to have similar ages at onset of disease compared to heterozygous sibs. We have investigated this phenomenon using a cell culture model. Protein aggregate formation was used as an indicator for pathology, as intraneuronal huntingtin inclusions are associated with pathology in vitro and in vivo. We showed that cytoplasmic and nuclear aggregates are formed by constructs comprising part of exon 1 of huntingtin with 41, 51, 66, or 72 CAG repeats, in a rate that correlates with repeat number. No inclusions were seen with 21 CAG repeat constructs. Mutant and wild type huntingtin fragments can be sequestered into inclusions seeded by a mutant huntingtin. Wild type huntingtin did not enhance or interfere with protein aggregation. The rate of protein aggregation was dose dependent for all mutant constructs tested. These experiments suggested a model for the dominance observed in HD; the decrease in the age at onset of a mutant homozygote may be small compared to the variance in the age at onset for that specific repeat number in heterozygotes. Our experiments also provide a model, which may explain the different repeat size ranges seen in patients and healthy controls for the different polyglutamine diseases.
Similar articles
-
Wild type Huntingtin reduces the cellular toxicity of mutant Huntingtin in mammalian cell models of Huntington's disease.J Med Genet. 2001 Jul;38(7):450-2. doi: 10.1136/jmg.38.7.450. J Med Genet. 2001. PMID: 11432963 Free PMC article.
-
Mutant huntingtin promotes the fibrillogenesis of wild-type huntingtin: a potential mechanism for loss of huntingtin function in Huntington's disease.J Biol Chem. 2003 Oct 17;278(42):41452-61. doi: 10.1074/jbc.M303354200. Epub 2003 Jul 29. J Biol Chem. 2003. PMID: 12888569
-
Rapid aggregate formation of the huntingtin N-terminal fragment carrying an expanded polyglutamine tract.Biochem Biophys Res Commun. 1999 Mar 16;256(2):361-6. doi: 10.1006/bbrc.1999.0337. Biochem Biophys Res Commun. 1999. PMID: 10079189
-
Juvenile Huntington's disease: does a dosage-effect pathogenic mechanism differ from the classical adult disease?Mech Ageing Dev. 2006 Feb;127(2):208-12. doi: 10.1016/j.mad.2005.09.012. Epub 2005 Nov 7. Mech Ageing Dev. 2006. PMID: 16274727 Review.
-
Huntington's disease: from pathology and genetics to potential therapies.Biochem J. 2008 Jun 1;412(2):191-209. doi: 10.1042/BJ20071619. Biochem J. 2008. PMID: 18466116 Review.
Cited by
-
Interferon-β-induced miR-1 alleviates toxic protein accumulation by controlling autophagy.Elife. 2019 Dec 4;8:e49930. doi: 10.7554/eLife.49930. Elife. 2019. PMID: 31799933 Free PMC article.
-
The first year.Acta Neuropathol. 2020 Jan;139(1):1-2. doi: 10.1007/s00401-019-02113-w. Epub 2019 Dec 12. Acta Neuropathol. 2020. PMID: 31832772 No abstract available.
-
Polyglutamine aggregates alter protein folding homeostasis in Caenorhabditis elegans.Proc Natl Acad Sci U S A. 2000 May 23;97(11):5750-5. doi: 10.1073/pnas.100107297. Proc Natl Acad Sci U S A. 2000. PMID: 10811890 Free PMC article.
-
Autophagy inhibition compromises degradation of ubiquitin-proteasome pathway substrates.Mol Cell. 2009 Feb 27;33(4):517-27. doi: 10.1016/j.molcel.2009.01.021. Mol Cell. 2009. PMID: 19250912 Free PMC article.
-
The HSPB1-p62/SQSTM1 functional complex regulates the unconventional secretion and transcellular spreading of the HD-associated mutant huntingtin protein.Hum Mol Genet. 2023 Jul 4;32(14):2269-2291. doi: 10.1093/hmg/ddad047. Hum Mol Genet. 2023. PMID: 36971475 Free PMC article.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials